<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-93-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-12-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Valproate and EEG Abnormalities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>12</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>12</issue>
<fpage>93</fpage>
<lpage>93</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1212/WNL.42.10.2003" vol="42" page="2003">
<article-title>Valproate acute administration, EEG epileptic abnormalities, and ammonemia</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The effect of valproate on EEG epileptic abnormalities was investigated at the Institute of Neurophysiology, Genoa, Italy.</p>
</abstract>
<kwd-group>
<kwd>Valproate</kwd>
<kwd>Ammonia</kwd>
<kwd>EEG Abnormalities</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The effect of valproate on EEG epileptic abnormalities was investigated at the Institute of Neurophysiology, Genoa, Italy. Sixteen patients aged 14 to 44 years were administered a single (14-37 mg/kg) oral dose of magnesium valproate. At peak serum concentrations of 65-139 ug/ml of valproate, there were increases in spike wave frequency at 2, 3, 4 and 5 hours. The peak concentrations of ammonia ranged from 15-72 ug/1, with values exceeding normal in 13 determinations. The VPA and ammonia concentrations varied independently. The frequency of EEG epileptic abnormalities was not correlated with either the ammonemia level or the amount of variation in ammonemia concentration. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> A direct CNS drug action has been proposed to explain the quantitative EEG abnormalities in response to acute VPA administration and the stupor states in some patients. The stupor was not necessarily related to the increased ammonia concentration in the blood.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sannita</surname>
<given-names>WG</given-names>
</name>
</person-group>
<article-title>Valproate acute administration, EEG epileptic abnormalities, and ammonemia</article-title>
<source>Neurology</source>
<year>1992</year>
<month>Oct</month>
<volume>42</volume>
<issue>10</issue>
<fpage>2003</fpage>
<lpage>2005</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.42.10.2003</pub-id>
<pub-id pub-id-type="pmid">1407583</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>